enGene Holdings Inc., a clinical-stage biotech company, focuses on developing genetic medicines delivered to mucosal tissues. Their lead product, EG-70, is a non-viral immunotherapy for treating non-muscle invasive bladder cancer patients.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing